FYC
First Trust Small Cap Growth AlphaDEX Fund
First Trust Small Cap Value AlphaDEX Fund seeks investment results that correspond to the Defined Small Cap Value Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.3 B
ASSETS UNDER MGMT
71 bp
EXPENSES
Fund Basics
| Inception date | Apr 19, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| OM ASSET MANAGEMENT PLC | 0.8 % |
| FIRST ADVANTAGE CORP. | 0.7 % |
| FAMOUS DAVE'S OF AMERICA | 0.7 % |
| OSCAR HEALTH, INC. CLASS A | 0.7 % |
| HINGE HEALTH INC-A | 0.7 % |
| RELAY THERAPEUTICS, INC. | 0.7 % |
| REAL INDUSTRY, INC. | 0.7 % |
| PITNEY BOWES INC | 0.7 % |
| NLIGHT, INC. | 0.7 % |
| SHOALS TECHNOLOGIES GROUP, INC. CLASS A | 0.7 % |
Constituent Breakdown
| Number of holdings | 265 |
| Herfindahl-Hirschman Index | 47 |
| Wgt avg mkt cap (mns) | $3,042 |
| Large cap (>$10bn) | 0.5% |
| Mid cap ($2-10bn) | 71.5% |
| Small cap (<$2bn) | 26.0% |
| Developed mkts. | 97.7% |
| Emerging mkts. | 0.7% |
Sector Breakdown
Country Exposure
| UNITED STATES | 94.7 % | |
| CHINA | 0.7 % | |
| IRELAND | 0.7 % | |
| COSTA RICA | 0.5 % | |
| LUXEMBOURG | 0.5 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 32.5% | 60.0% | 39.0% | 28.4% | 11.7% | 15.1% | -- | 12.8% |
| Dividend Yield | 0.1% | 0.3% | 0.6% | 0.6% | 0.5% | 0.4% | -- | 0.3% |
| Total Returns | 32.6% | 60.3% | 39.6% | 28.9% | 12.2% | 15.4% | -- | 13.1% | Ann. Volatility | 22.5% | 21.6% | 23.5% | 22.1% | 23.7% | 24.6% | -- | 23.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.42 | 67% |
| MSCI EAFE | 0.97 | 49% |
| MSCI Emg Mkts | 0.65 | 47% |
Liquidity Measures
| Avg. volume (000) | 61 |
| ADV traded (mns) | $7 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.25% |
Technical Indicators
| 30d moving avg. (EMA) | $119.87 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 1.99/2.41 |
| Bollinger Bands (Upper/Lower) | $127.21/$116.21 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FYC |
Expenses vs. FYC |
ALTAR Score™ vs. FYC |
|---|---|---|---|---|
| FYX | First Trust Small Cap Core AlphaDEX Fund | 38.7% | -10 bp | +5.0% |
| IWO | iShares Russell 2000 Growth ETF | 24.5% | -47 bp | +0.9% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 23.8% | -56 bp | +4.0% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 23.4% | -53 bp | +3.9% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 22.0% | -61 bp | +3.9% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 20.0% | -7 bp | +2.0% |
| RSSL | Global X Russell 2000 ETF | 19.5% | -63 bp | +2.7% |
| AFSM | First Trust Active Factor Small Cap ETF | 19.3% | +4 bp | +6.2% |
| RZG | Invesco S&P Smallcap 600 Pure Growth ETF | 18.8% | -36 bp | +3.8% |
| EES | WisdomTree U.S. SmallCap Fund | 18.8% | -33 bp | +8.3% |
Risk and Returns: FYC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/17/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.4%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,401 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. FYC's ALTAR Score™ is approximately -2.4 standard
deviations above the category average. This places FYC in the 1st percentile
among funds in the category.
Sell-Side Consensus
$127
PRICE TARGET
+5.0%
UPSIDE